Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Traffic & App Usage Insights

Discover domain traffic and app usage trends for companies and their competitors.

Last Close
Nov 08 04:00PM ET
61.12
Dollar change
+3.07
Percentage change
5.29
%
IndexRUT P/E- EPS (ttm)-2.28 Insider Own38.29% Shs Outstand37.17M Perf Week12.17%
Market Cap3.76B Forward P/E- EPS next Y-3.80 Insider Trans-0.80% Shs Float36.09M Perf Month13.37%
Income-118.48M PEG- EPS next Q-0.78 Inst Own80.12% Short Float19.02% Perf Quarter37.47%
Sales0.00M P/S- EPS this Y16.91% Inst Trans6.53% Short Ratio17.47 Perf Half Y14.84%
Book/sh13.65 P/B4.48 EPS next Y-35.98% ROA-25.44% Short Interest6.87M Perf Year277.28%
Cash/sh10.98 P/C5.57 EPS next 5Y- ROE-26.73% 52W Range14.19 - 72.29 Perf YTD118.75%
Dividend Est.- P/FCF- EPS past 5Y- ROI-15.27% 52W High-15.45% Beta2.87
Dividend TTM- Quick Ratio27.70 Sales past 5Y0.00% Gross Margin- 52W Low330.73% ATR (14)2.88
Dividend Ex-Date- Current Ratio27.70 EPS Y/Y TTM- Oper. Margin0.00% RSI (14)64.26 Volatility5.89% 5.03%
Employees- Debt/Eq0.01 Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price88.67
Option/ShortYes / Yes LT Debt/Eq0.00 EPS Q/Q-60.56% Payout- Rel Volume1.04 Prev Close58.05
Sales Surprise- EPS Surprise-2.98% Sales Q/Q- EarningsAug 12 BMO Avg Volume393.01K Price61.12
SMA2010.74% SMA5012.67% SMA20024.05% Trades Volume407,357 Change5.29%
Date Action Analyst Rating Change Price Target Change
May-10-24Initiated BofA Securities Buy $80
Dec-20-23Initiated BTIG Research Buy $43
Aug-08-23Initiated Wedbush Outperform $40
Aug-08-23Initiated TD Cowen Outperform
Aug-08-23Initiated Stifel Buy $34
Aug-08-23Initiated Jefferies Buy $29
Aug-08-23Initiated Guggenheim Buy $29
Nov-04-24 07:30AM
Oct-24-24 08:00AM
Oct-16-24 07:00AM
Oct-07-24 04:50PM
Oct-04-24 01:03PM
07:00AM Loading…
Sep-12-24 07:00AM
Sep-09-24 07:00AM
Sep-07-24 01:45AM
Aug-24-24 01:30AM
Aug-19-24 07:00AM
Aug-12-24 06:30AM
Aug-10-24 01:00AM
01:00AM
Jul-18-24 08:00AM
Jul-06-24 01:00AM
01:00AM Loading…
01:00AM
May-28-24 07:30AM
May-23-24 07:30AM
May-15-24 04:01PM
May-13-24 01:53PM
07:42AM
07:00AM
May-10-24 10:13AM
May-08-24 01:28PM
May-06-24 08:00AM
Apr-03-24 07:49AM
Mar-28-24 11:01AM
Mar-25-24 07:00AM
07:00AM
Mar-12-24 04:01PM
06:49PM Loading…
Mar-07-24 06:49PM
Mar-05-24 10:53PM
04:23PM
04:16PM
07:35AM
07:35AM
06:10AM
06:00AM
06:00AM
Mar-04-24 04:01PM
Jan-02-24 07:30AM
Nov-15-23 04:44AM
Nov-13-23 07:30AM
Oct-30-23 08:00AM
Oct-23-23 02:50AM
Sep-27-23 08:42AM
Sep-14-23 07:30AM
Aug-29-23 08:00AM
Aug-28-23 07:30AM
Aug-21-23 07:30AM
Aug-10-23 02:29PM
Aug-08-23 10:02AM
Aug-07-23 07:30AM
Aug-04-23 06:30PM
Aug-02-23 07:30AM
Jul-18-23 04:01PM
Apogee Therapeutics, Inc. operates as a biotechnology company. It offers treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD) and related inflammatory and immunology (I&I) indications. The company was founded in 2022 and is headquartered in Waltham, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Dambkowski CarlChief Medical OfficerNov 06 '24Sale59.126,665394,041267,463Nov 08 08:02 PM
HENDERSON MICHAEL THOMASChief Executive OfficerNov 06 '24Sale59.2215,000888,3201,339,487Nov 08 08:01 PM
HENDERSON MICHAEL THOMASOfficerNov 06 '24Proposed Sale59.2315,000888,388Nov 06 11:39 AM
Dambkowski CarlChief Medical OfficerOct 02 '24Sale56.266,665374,954274,128Oct 04 08:02 PM
HENDERSON MICHAEL THOMASChief Executive OfficerOct 02 '24Sale56.2340,0002,249,3071,354,487Oct 04 08:01 PM
CARL DAMBKOWSKIOfficerOct 02 '24Proposed Sale57.3116,010917,533Oct 02 04:20 PM
HENDERSON MICHAEL THOMASOfficerOct 02 '24Proposed Sale56.2340,0002,249,176Oct 02 02:34 PM
Dambkowski CarlChief Medical OfficerSep 04 '24Sale47.566,665316,969280,793Sep 06 08:03 PM
HENDERSON MICHAEL THOMASChief Executive OfficerSep 04 '24Sale47.6240,0001,904,8411,394,487Sep 06 08:02 PM
HENDERSON MICHAEL THOMASOfficerSep 04 '24Proposed Sale47.6240,0001,904,848Sep 04 01:35 PM
Henderson JaneChief Financial OfficerAug 23 '24Sale48.266,000289,560200,871Aug 23 08:05 PM
JANE V HENDERSONOfficerAug 23 '24Proposed Sale48.266,000289,570Aug 23 04:09 PM
Dambkowski CarlChief Medical OfficerAug 07 '24Sale40.677,335298,336287,458Aug 09 08:05 PM
HENDERSON MICHAEL THOMASChief Executive OfficerAug 07 '24Sale40.6240,0001,624,7641,434,487Aug 09 08:05 PM
HENDERSON MICHAEL THOMASOfficerAug 07 '24Proposed Sale40.6240,0001,624,784Aug 07 01:18 PM
HENDERSON MICHAEL THOMASChief Executive OfficerJul 05 '24Sale37.2615,000558,9001,474,487Jul 05 08:01 PM
Dambkowski CarlChief Medical OfficerJul 03 '24Sale37.605,995225,418294,793Jul 05 08:01 PM